Amyloid beta deregulates astroglial mGluR5-mediated calcium signaling via calcineurin and Nf-kB

GLIA

Volumn 61, Issue 7, 2013, Pages 1134-1145

  Lim, Dmitry ^a   Iyer, Anand ^b   Ronco, Virginia ^a   Grolla, Ambra A ^a   Canonico, Pier Luigi ^a   Aronica, Eleonora ^b,c,d   Genazzani, Armando A ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Alzheimer disease; Astrocytes; Metabotropic glutamate; NF kappa B p65; Receptors

Indexed keywords

AMYLOID BETA PROTEIN; CALCINEURIN; CALCIUM; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METABOTROPIC RECEPTOR 5; PROTEIN BCL 10;

AGED; ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; ASTROCYTE; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CELL CULTURE; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; GLIA CELL; HIPPOCAMPUS; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RAT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; BORON COMPOUNDS; CALCINEURIN; CALCIUM; CALCIUM SIGNALING; CELLS, CULTURED; CHELATING AGENTS; EGTAZIC ACID; ENZYME INHIBITORS; FEMALE; HIPPOCAMPUS; HUMANS; MALE; NEOPLASM PROTEINS; NF-KAPPA B; NUCLEOCYTOPLASMIC TRANSPORT PROTEINS; PEPTIDE FRAGMENTS; RATS; RECEPTOR, METABOTROPIC GLUTAMATE 5; UP-REGULATION;

EID: 84879605797     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22502     Document Type: Article

References (50)

1. Abdul HM, Baig I, Levine H III, Guttmann RP, Norris CM. Proteolysis of calcineurin is increased in human hippocampus during mild cognitive impairment and is stimulated by oligomeric Abeta in primary cell culture. Aging Cell 2011;10:103-113.
2. Abdul HM, Sama MA, Furman JL, Mathis DM, Beckett TL, Weidner AM, Patel ES, Baig I, Murphy MP, LeVine H III, Kraner SD, Norris CM. Cognitive decline in Alzheimer's disease is associated with selective changes in calcineurin/NFAT signaling. J Neurosci 2009;29:12957-12969.
3. Abramov AY, Canevari L, Duchen MR. Calcium signals induced by amyloid beta peptide and their consequences in neurons and astrocytes in culture. Biochim Biophys Acta 2004;1742:81-87.
4. Aguzzi A, Haass C. Games played by rogue proteins in prion disorders and Alzheimer's disease. Science 2003;302:814-818.
5. Aronica E, Gorter JA, Jansen GH, van Veelen CW, van Rijen PC, Ramkema M, Troost D. Expression and cell distribution of group I and group II metabotropic glutamate receptor subtypes in taylor-type focal cortical dysplasia. Epilepsia 2003;44:785-795.
6. Bettegazzi B, Mihailovich M, Di Cesare A, Consonni A, Macco R, Pelizzoni I, Codazzi F, Grohovaz F, Zacchetti D. Beta-Secretase activity in rat astrocytes: Translational block of BACE1 and modulation of BACE2 expression. Eur J Neurosci 2011;33:236-243.
7. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 2006;112:389-404.
8. Canellada A, Ramirez BG, Minami T, Redondo JM, Cano E. Calcium/calcineurin signaling in primary cortical astrocyte cultures: Rcan1-4 and cyclooxygenase-2 as NFAT target genes. Glia 2008;56:709-722.
9. Corti C, Clarkson RW, Crepaldi L, Sala CF, Xuereb JH, Ferraguti F. Gene structure of the human metabotropic glutamate receptor 5 and functional analysis of its multiple promoters in neuroblastoma and astroglioma cells. J Biol Chem 2003;278:33105-33119.
10. Demuro A, Parker I, Stutzmann GE. Calcium signaling and amyloid toxicity in Alzheimer disease. J Biol Chem 2010;285:12463-12468.
11. DeWitt DA, Perry G, Cohen M, Doller C, Silver J. Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease. Exp Neurol 1998;149:329-40.
12. Fernandez AM, Jimenez S, Mecha M, Dávila D, Guaza C, Vitorica J, Torres-Aleman I. Regulation of the phosphatase calcineurin by insulin-like growth factor I unveils a key role of astrocytes in Alzheimer's pathology. Mol Psychiatry 2012;17:705-718.
13. Fresu L, Dehpour A, Genazzani AA, Carafoli E, Guerini D. Plasma membrane calcium ATPase isoforms in astrocytes. Glia 1999;28:150-155.
14. Frischbutter S, Gabriel C, Bendfeldt H, Radbruch A, Baumgrass R. Dephosphorylation of Bcl-10 by calcineurin is essential for canonical NF-κB activation in Th cells. Eur J Immunol 2011;41:2349-2357.
15. Furman JL, Artiushin IA, Norris CM. Disparate effects of serum on basal and evoked NFAT activity in primary astrocyte cultures. Neurosci Lett 2010;469:365-369.
16. Furman JL, Sama DM, Gant JC, Beckett TL, Murphy MP, Bachstetter AD, Van Eldik LJ, Norris CM. Targeting astrocytes ameliorates neurologic changes in a mouse model of Alzheimer's disease. J Neurosci 2012;32:16129-16140.
17. Giuffrida ML, Caraci F, Pignataro B, Cataldo S, De Bona P, Bruno V, Molinaro G, Pappalardo G, Messina A, Palmigiano A, Garozzo D, Nicoletti F, Rizzarelli E, Copani A. Beta-amyloid monomers are neuroprotective. J Neurosci 2009;29:10582-10587.
18. Graef IA, Mermelstein PG, Stankunas K, Neilson JR, Deisseroth K, Tsien RW, Crabtree GR. L-type calcium channels and GSK-3 regulate the activity of NF-ATc4 in hippocampal neurons. Nature 1999;401:703-708.
19. Grolla AA, Fakhfouri G, Balzaretti G, Marcello E, Gardoni F, Canonico PL, Diluca M, Genazzani AA, Lim D. Aβ leads to Ca(2+) signaling alterations and transcriptional changes in glial cells. Neurobiol Aging 2013;34:511-522.
20. Groth RD, Mermelstein PG. Brain-derived neurotrophic factor activation of NFAT (nuclear factor of activated T-cells)-dependent transcription: A role for the transcription factor NFATc4 in neurotrophin-mediated gene expression. J Neurosci 2003;23:8125-8134.
21. Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440-3450.
22. Guerini D, García-Martin E, Gerber A, Volbracht C, Leist M, Merino CG, Carafoli E. The expression of plasma membrane Ca2+ pump isoforms in cerebellar granule neurons is modulated by Ca2+. J Biol Chem 1999;274:1667-1676.
23. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 2002;297:353-356.
24. Jin SM, Cho HJ, Kim YW, Hwang JY, Mook-Jung I. Aβ-induced Ca(2+) influx regulates astrocytic BACE1 expression via calcineurin/NFAT4 signals. Biochem Biophys Res Commun 2012;425:649-655.
25. Kagan BL, Thundimadathil J. Amyloid peptide pores and the beta sheet conformation. Adv Exp Med Biol 2010;677:150-167.
26. Kawahara M, Kuroda Y. Molecular mechanism of neurodegeneration induced by Alzheimer's beta-amyloid protein: Channel formation and disruption of calcium homeostasis. Brain Res Bull 2000;53:389-397.
27. Kuchibhotla KV, Goldman ST, Lattarulo CR, Wu HY, Hyman BT, Bacskai BJ. Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks. Neuron 2008;59:214-225.
28. Kuchibhotla KV, Lattarulo CR, Hyman BT, Bacskai BJ. Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice. Science 2009;323:1211-1215.
29. Kulijewicz-Nawrot M, Verkhratsky A, Chvátal A, Syková E, Rodríguez JJ. Astrocytic cytoskeletal atrophy in the medial prefrontal cortex of a triple transgenic mouse model of Alzheimer's disease. J Anat 2012;221:252-262.
30. Lee JI, Burckart GJ. Nuclear factor kappa B: Important transcription factor and therapeutic target. J Clin Pharmacol 1998;38:981-993.
31. Luron L, Saliba D, Blazek K, Lanfrancotti A, Udalova IA. FOXO3 as a new IKK-ε-controlled check-point of regulation of IFN-β expression. Eur J Immunol 2012;42:1030-1037.
32. Marcello E, Gardoni F, Mauceri D, Romorini S, Jeromin A, Epis R, Borroni B, Cattabeni F, Sala C, Padovani A, Di Luca M. Synapse-associated protein-97 mediates alpha-secretase ADAM10 trafficking and promotes its activity. J Neurosci 2007;27:1682-1691.
33. Mehta PD, Pirttila T, Patrick BA, Barshatzky M, Mehta SP. Amyloid beta protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease. Neurosci Lett 2001;304:102-106.
34. Norris CM, Kadish I, Blalock EM, Chen KC, Thibault V, Porter NM, Landfield PW, Kraner SD. Calcineurin triggers reactive/inflammatory processes in astrocytes and is upregulated in aging and Alzheimer's models. J Neurosci 2005;25:4649-4658.
35. Palkowitsch L, Marienfeld U, Brunner C, Eitelhuber A, Krappmann D, Marienfeld RB. The Ca2+-dependent phosphatase calcineurin controls the formation of the Carma1-Bcl10-Malt1 complex during T cell receptor-induced NF-kappaB activation. J Biol Chem 2011;286:7522-7534.
36. Parpura V, Heneka MT, Montana V, Oliet SH, Schousboe A, Haydon PG, Stout RFJr, Spray DC, Reichenbach A, Pannicke T, Pekny M, Pekna M, Zorec R. Glial cells in (patho)physiology. J Neurochem 2012;121:4-27.
37. Pellistri F, Bucciantini M, Relini A, Nosi D, Gliozzi A, Robello M, Stefani M. Nonspecific interaction of prefibrillar amyloid aggregates with glutamatergic receptors results in Ca2+ increase in primary neuronal cells. J Biol Chem 2008;283:29950-29960.
38. Pérez-Ortiz JM, Serrano-Pérez MC, Pastor MD, Martín ED, Calvo S, Rincón M, Tranque P. Mechanical lesion activates newly identified NFATc1 in primary astrocytes: Implication of ATP and purinergic receptors. Eur J Neurosci 2008;27:2453-2465.
39. Peters O, Schipke CG, Philipps A, Haas B, Pannasch U, Wang LP, Benedetti B, Kingston AE, Kettenmann H. Astrocyte function is modified by Alzheimer's disease-like pathology in aged mice. J Alzheimers Dis 2009;18:177-189.
40. Reese LC, Taglialatela G. A role for calcineurin in Alzheimer's disease. Curr Neuropharmacol 2011;9:685-692.
41. Rodríguez JJ, Verkhratsky A. Neuroglial roots of neurodegenerative diseases?Mol Neurobiol 2011;43:87-96.
42. Rossner S, Lange-Dohna C, Zeitschel U, Perez-Polo JR. Alzheimer's disease beta-secretase BACE1 is not a neuron-specific enzyme. J Neurochem 2005;92:226-234.
43. Rubio-Perez JM, Morillas-Ruiz JM. A review: Inflammatory process in Alzheimer's disease, role of cytokines. Sci World J 2012;2012:756357.
44. Sama MA, Mathis DM, Furman JL, Abdul HM, Artiushin IA, Kraner SD, Norris CM. Interleukin-1beta-dependent signaling between astrocytes and neurons depends critically on astrocytic calcineurin/NFAT activity. J Biol Chem 2008;283:21953-21964.
45. Sharp AH, Nucifora FCJr, Blondel O, Sheppard CA, Zhang C, Snyder SH, Russell JT, Ryugo DK, Ross CA. Differential cellular expression of isoforms of inositol 1, 4, 5-triphosphate receptors in neurons and glia in brain. J Comp Neurol 1999;406:207-220.
46. Supnet C, Bezprozvanny I. The dysregulation of intracellular calcium in Alzheimer disease. Cell Calcium 2010;47:183-189.
47. Thibault O, Gant JC, Landfield PW. Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: Minding the store. Aging Cell 2007;6:307-317.
48. Tu H, Nelson O, Bezprozvanny A, Wang Z, Lee SF, Hao YH, Serneels L, De Strooper B, Yu G, Bezprozvanny I. Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations. Cell 2006;126:981-993.
49. Verkhratsky A, Sofroniew MV, Messing A, deLanerolle NC, Rempe D, Rodríguez JJ, Nedergaard M. Neurological diseases as primary gliopathies: A reassessment of neurocentrism. ASN Neuro 2012;4:art:e00082.
50. Yeh CY, Vadhwana B, Verkhratsky A, Rodríguez JJ. Early astrocytic atrophy in the entorhinal cortex of a triple transgenic animal model of Alzheimer's disease. ASN Neurol 2011;3:271-279.